Selected article for: "acute respiratory syndrome sars and admission symptom"

Author: Jourdes, Aurélie; Lafaurie, Margaux; Martin-Blondel, Guillaume; Delobel, Pierre; Faruch, Marie; Charpentier, Sandrine; Minville, Vincent; Silva, Stein; Thalamas, Claire; Sommet, Agnès; Moulis, Guillaume
Title: Clinical characteristics and outcome of hospitalized patients with SARS-CoV-2 infection at Toulouse University hospital (France). Results from the Covid-clinic-Toul cohort
  • Cord-id: sl42tq5k
  • Document date: 2020_10_7
  • ID: sl42tq5k
    Snippet: Background Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection has spread worldwide from epicenter of Wuhan, China since December 2019. The aim of our study was to describe the clinical characteristics and outcome of hospitalized patients with SARS-CoV-2 pneumonia at the Toulouse university hospital, France. Patients and methods We selected the patients included from March 7, 2020 to April 20, 2020 in the retrolective Covid-clinic-Toul cohort that follows all hospitalized pati
    Document: Background Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection has spread worldwide from epicenter of Wuhan, China since December 2019. The aim of our study was to describe the clinical characteristics and outcome of hospitalized patients with SARS-CoV-2 pneumonia at the Toulouse university hospital, France. Patients and methods We selected the patients included from March 7, 2020 to April 20, 2020 in the retrolective Covid-clinic-Toul cohort that follows all hospitalized patients with SARS-CoV-2 infection at the Toulouse Hospital. Cases were confirmed by real-time reverse transcriptase polymerase chain reaction. We report demographics, clinical, biological and radiological features, as well as unfavorable outcome at Day 14 after admission (admission in an intensive care unit, mechanical ventilation, death). Results Among263 hospitalized patients, the median age was 65 years and 155 (58.9%) were males. Two hundred and twenty-seven patients (86.3%) had at least one comorbidity. The median time from first symptom to hospital admission was 7.0 days (interquartile range: 4-10). On day 14 after admission, 111 patients (42.2%) had been transferred to intensive care unit (ICU), including 50 (19.0%) on Day 1; 61 (23.1%) needed mechanical ventilation and 19 patients (7.2%) had died. Patients admitted to ICU at Day 1 of admission (n=50) were more frequently men (66.0% vs 57.3%), smokers (25.0% vs 7.1%), with obesity (42.0% vs 24.7%) and had a higher mean level of C-reactive protein (median: 110.9mg/L vs 46.2mg/L). Conclusion This cohort provides epidemiological data on SARS-CoV-2 in hospitalized patients in a University hospital in the South of France.

    Search related documents:
    Co phrase search for related documents
    • acute ards respiratory distress syndrome and admission symptom: 1, 2, 3, 4
    • acute ards respiratory distress syndrome and lopinavir ritonavir: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute ards respiratory distress syndrome and lung lesion: 1
    • acute ards respiratory distress syndrome and lymphocyte count: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute heart failure and admission follow: 1
    • acute heart failure and admission symptom: 1
    • acute heart failure and admission symptom time: 1
    • acute heart failure and lopinavir ritonavir: 1
    • acute heart failure and lung lesion: 1
    • acute heart failure and lymphocyte count: 1, 2, 3, 4, 5, 6
    • admission follow and lopinavir ritonavir: 1, 2
    • admission follow and lymphocyte count: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
    • admission symptom and lung lesion: 1
    • admission symptom and lymphocyte count: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
    • admission symptom time and lymphocyte count: 1, 2, 3, 4, 5
    • lopinavir ritonavir and lung lesion: 1, 2
    • lopinavir ritonavir and lymphocyte count: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
    • lung lesion and lymphocyte count: 1, 2, 3, 4, 5, 6